Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, announced that its CEO, Rob Claypoole, will present at the 43rd Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, announced that its CEO, Rob Claypoole, will present at the 43rd Annual J.P. Morgan Healthcare Conference.
The presentation is scheduled for Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET). A live webcast, including a Q&A session, will be accessible on the Investors section of the Bioventus website. This webcast will be available until February 15, 2025.
Details
News Market Reaction – BVS
The recorded move for BVS in the trading session of this news was -2.85%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET).
The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available until February 15, 2025.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.